NO20070206L - Sammensetninger inneholdende strontium og vitamin D og anvendelser derav - Google Patents
Sammensetninger inneholdende strontium og vitamin D og anvendelser deravInfo
- Publication number
- NO20070206L NO20070206L NO20070206A NO20070206A NO20070206L NO 20070206 L NO20070206 L NO 20070206L NO 20070206 A NO20070206 A NO 20070206A NO 20070206 A NO20070206 A NO 20070206A NO 20070206 L NO20070206 L NO 20070206L
- Authority
- NO
- Norway
- Prior art keywords
- vitamin
- strontium
- compositions containing
- containing strontium
- pharmaceutical composition
- Prior art date
Links
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 3
- 229930003316 Vitamin D Natural products 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000019166 vitamin D Nutrition 0.000 title abstract 2
- 239000011710 vitamin D Substances 0.000 title abstract 2
- 229940046008 vitamin d Drugs 0.000 title abstract 2
- 229910052712 strontium Inorganic materials 0.000 title 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 159000000008 strontium salts Chemical class 0.000 abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229910000018 strontium carbonate Inorganic materials 0.000 abstract 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical class [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 abstract 1
- -1 vitamin D compound Chemical class 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400991 | 2004-06-25 | ||
| DKPA200401733 | 2004-11-10 | ||
| PCT/DK2005/000425 WO2006000224A2 (en) | 2004-06-25 | 2005-06-24 | Compositions comprising strontium and vitamin d and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20070206L true NO20070206L (no) | 2007-03-22 |
Family
ID=34972075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20070206A NO20070206L (no) | 2004-06-25 | 2007-01-11 | Sammensetninger inneholdende strontium og vitamin D og anvendelser derav |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8658206B2 (enExample) |
| EP (1) | EP1768748B2 (enExample) |
| JP (2) | JP5070046B2 (enExample) |
| KR (1) | KR20070034075A (enExample) |
| AT (1) | ATE443541T1 (enExample) |
| AU (1) | AU2005256317B2 (enExample) |
| BR (1) | BRPI0512357A (enExample) |
| CA (1) | CA2571449C (enExample) |
| DE (1) | DE602005016803D1 (enExample) |
| DK (1) | DK1768748T4 (enExample) |
| EA (1) | EA011814B1 (enExample) |
| IL (1) | IL180144A0 (enExample) |
| MX (1) | MXPA06015187A (enExample) |
| NO (1) | NO20070206L (enExample) |
| WO (1) | WO2006000224A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080118603A1 (en) * | 2006-11-21 | 2008-05-22 | Lada Mark W | Nutritional beverage for optimal bone health |
| WO2008061535A1 (en) * | 2006-11-21 | 2008-05-29 | Strontin Aps | Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases. |
| ES2573327T3 (es) * | 2007-04-23 | 2016-06-07 | Baxter International Inc. | Composiciones de fibrina que contienen compuestos de estroncio |
| WO2009010305A2 (en) * | 2007-07-19 | 2009-01-22 | Dsm Ip Assets B.V. | Tablettable formulations of lipophilic health ingredients |
| US8790714B2 (en) | 2007-08-03 | 2014-07-29 | Nucitec, S.A. De C.V. | Compositions and methods for treatment and prevention of osteoarthritis |
| EP2416756A2 (en) * | 2009-04-10 | 2012-02-15 | Mahmut Bilgic | Stable pharmaceutical compositions with high bioavailibility |
| FR2945748A1 (fr) * | 2009-05-20 | 2010-11-26 | Debregeas Et Associes Pharma | Medicament a base de calcium et de vitamine d. |
| FR2953139B1 (fr) * | 2009-11-27 | 2012-04-13 | Servier Lab | Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine |
| EP2591354B1 (en) * | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| EP2590656B1 (en) | 2010-07-07 | 2017-11-15 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| JP5827328B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス，インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
| EP2590965B1 (en) | 2010-07-07 | 2016-04-20 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| JP5827326B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス，インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
| AU2012212385B2 (en) * | 2011-02-02 | 2015-01-15 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of nasal passages |
| EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| WO2014044756A1 (en) * | 2012-09-20 | 2014-03-27 | Mokwalo SA | Strontium as anti microbial compound |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3345265A (en) * | 1963-10-09 | 1967-10-03 | Kendall & Co | Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating |
| US3699221A (en) * | 1965-02-23 | 1972-10-17 | Murray L Schole | Dental preparations |
| US3988434A (en) | 1972-08-07 | 1976-10-26 | Schole Murray L | Dental preparation |
| FR2633619B1 (fr) | 1988-06-29 | 1991-02-08 | Adir | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant |
| FR2651497B1 (fr) | 1989-09-01 | 1991-10-25 | Adir | Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| FR2658816A1 (fr) * | 1990-02-27 | 1991-08-30 | Adir | Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5380530A (en) | 1992-12-29 | 1995-01-10 | Whitehill Oral Technologies | Oral care composition coated gum |
| US5624906A (en) * | 1994-12-08 | 1997-04-29 | Lever Brothers Company, Division Of Conopco, Inc. | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds |
| FR2749759B1 (fr) | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
| CN1164603C (zh) | 2001-09-29 | 2004-09-01 | 南京化工大学 | 1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用 |
| FR2844797B1 (fr) | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
| FR2844796A1 (fr) | 2002-09-24 | 2004-03-26 | Servier Lab | Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
| FR2844795B1 (fr) | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates |
| PT1534305E (pt) | 2003-05-07 | 2007-02-28 | Osteologix As | Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis |
| PT1622630E (pt) | 2003-05-07 | 2012-10-11 | Osteologix As | Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso |
| US20060216358A1 (en) * | 2003-05-07 | 2006-09-28 | Christian Hansen | Controlled release composition containing a strontium salt |
-
2005
- 2005-06-24 DK DK05750580.2T patent/DK1768748T4/da active
- 2005-06-24 EP EP05750580.2A patent/EP1768748B2/en not_active Expired - Lifetime
- 2005-06-24 JP JP2007516973A patent/JP5070046B2/ja not_active Expired - Fee Related
- 2005-06-24 MX MXPA06015187A patent/MXPA06015187A/es not_active Application Discontinuation
- 2005-06-24 CA CA2571449A patent/CA2571449C/en not_active Expired - Fee Related
- 2005-06-24 EA EA200700130A patent/EA011814B1/ru active IP Right Revival
- 2005-06-24 AT AT05750580T patent/ATE443541T1/de not_active IP Right Cessation
- 2005-06-24 US US11/570,767 patent/US8658206B2/en not_active Expired - Fee Related
- 2005-06-24 AU AU2005256317A patent/AU2005256317B2/en not_active Ceased
- 2005-06-24 WO PCT/DK2005/000425 patent/WO2006000224A2/en not_active Ceased
- 2005-06-24 DE DE602005016803T patent/DE602005016803D1/de not_active Expired - Lifetime
- 2005-06-24 KR KR1020077001916A patent/KR20070034075A/ko not_active Withdrawn
- 2005-06-24 BR BRPI0512357-7A patent/BRPI0512357A/pt not_active IP Right Cessation
-
2006
- 2006-12-18 IL IL180144A patent/IL180144A0/en unknown
-
2007
- 2007-01-11 NO NO20070206A patent/NO20070206L/no not_active Application Discontinuation
-
2012
- 2012-07-13 JP JP2012157477A patent/JP2012193208A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070034075A (ko) | 2007-03-27 |
| EP1768748A2 (en) | 2007-04-04 |
| JP2012193208A (ja) | 2012-10-11 |
| HK1102427A1 (en) | 2007-11-23 |
| JP5070046B2 (ja) | 2012-11-07 |
| DK1768748T4 (da) | 2019-06-11 |
| EA011814B1 (ru) | 2009-06-30 |
| EP1768748B2 (en) | 2019-03-13 |
| CA2571449C (en) | 2015-12-08 |
| DK1768748T3 (da) | 2010-02-01 |
| US8658206B2 (en) | 2014-02-25 |
| US20080026037A1 (en) | 2008-01-31 |
| WO2006000224A2 (en) | 2006-01-05 |
| CA2571449A1 (en) | 2006-01-05 |
| EA200700130A1 (ru) | 2007-06-29 |
| BRPI0512357A (pt) | 2008-03-04 |
| WO2006000224A3 (en) | 2006-05-18 |
| JP2008503504A (ja) | 2008-02-07 |
| MXPA06015187A (es) | 2007-09-27 |
| DE602005016803D1 (de) | 2009-11-05 |
| EP1768748B1 (en) | 2009-09-23 |
| IL180144A0 (en) | 2007-06-03 |
| AU2005256317A1 (en) | 2006-01-05 |
| ATE443541T1 (de) | 2009-10-15 |
| AU2005256317B2 (en) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2023022I1 (no) | cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate | |
| DK1768748T4 (da) | Sammensætninger omfattende strontium og vitamin D og anvendelser deraf | |
| IN2012DN01233A (enExample) | ||
| EA201070699A1 (ru) | Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| TW200732296A (en) | Novel compounds | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| TW200621313A (en) | Pharmaceutical compositions | |
| TW200738659A (en) | Novel compounds | |
| WO2007129066A8 (en) | 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer | |
| TW200716204A (en) | Pharmaceutical composition | |
| EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
| EA201170101A1 (ru) | Фармацевтические композиции роувастатина кальция | |
| GB0524814D0 (en) | Compounds | |
| TW200800993A (en) | Organic compounds | |
| ES2192136A1 (es) | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. | |
| TW200745081A (en) | Compounds | |
| IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
| DK1784173T3 (da) | Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater | |
| DK1893237T3 (da) | Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof | |
| GB0327390D0 (en) | Pharmaceutical formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |